Position in JNJ
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$15,891,918
+$664,284 QoQ
Shares Held
62,574
+0.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#857
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Dec 31, 2024CallValue
$289,240
CallShares
2,000
PutValue
$289,240
PutShares
2,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $209,939,553 across 14 Drug Manufacturers - General names. JNJ ranks #2 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
130,247 | $156,222,172 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
62,574 | $15,891,918 | |
| 3 | ABBV |
AbbVie Inc.
|
47,980 | $12,073,687 | |
| 4 | MRK |
Merck & Co., Inc.
|
54,116 | $6,953,906 | |
| 5 | AMGN |
Amgen Inc
|
17,375 | $6,291,835 | |
| 6 | PFE |
Pfizer Inc
|
169,378 | $4,078,622 | |
| 7 | AZN |
Astrazeneca PLC
|
9,817 | $1,861,499 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,784 | $1,716,154 |
All Filings in JNJ
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,891,918 | 62,574 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $15,227,634 | 62,296 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $15,005,323 | 72,507 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $14,201,688 | 76,592 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $12,164,551 | 79,637 | Shares | Sole | 2025-09-12 | |
| 2025-03-31 | $21,457,374 | 129,386 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $289,240 | 2,000 | Call | Sole | 2025-01-30 | |
| 2024-12-31 | $289,240 | 2,000 | Put | Sole | 2025-01-30 | |
| 2024-12-31 | $18,789,319 | 129,922 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $18,422,818 | 113,679 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $16,712,519 | 114,344 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $17,104,926 | 108,129 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $18,887,953 | 120,505 | Shares | Sole | 2024-01-29 | |
| 2023-12-31 | $62,696 | 400 | Call | Sole | 2024-01-29 | |
| 2023-09-30 | $18,895,745 | 121,321 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $19,739,087 | 119,255 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $18,418,185 | 118,827 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $19,580,945 | 110,846 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $17,271,236 | 105,725 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $18,702,808 | 105,362 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $19,183,020 | 108,238 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $17,393,029 | 101,672 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $16,555,365 | 102,510 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $15,912,895 | 96,594 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $15,775,299 | 95,986 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $18,539,521 | 117,801 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $8,064,978 | 54,171 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $7,701,039 | 54,761 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $6,613,803 | 50,437 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||